In both MYCN amplified and non-amplified neuroblastoma, CD44 was found to play a dual role that is when un-methylated was manifesting high expression levels, redirecting to tumor suppression, while when hyper-methylated it was related to tumor progression [162,163,164]. The gene discussed is MYCN; the disease is neuroblastoma.